Thursday, November 21, 2024
11/21/2024
Project Summary Substance use disorder (SUD) is characterized by recurrent drug-taking behaviors that often resemble the renewal-induced relapse after a successful extinction-based therapy. This inability of transferring the learned extinction as the subjects are re-exposed to the original drug context (i.e., their homes) is associated with deficits in neural regions such as the nucleus accumbens (NAc), which regulates the extinction of drug-associated memories and its ability to maintain voluntary abstinence. For instance, addicts developing addiction in a particular context “A” may extinguish the responses for drug-associated cues in a clinical context “B”, but when re-exposed to the same cues in context “A”, fail to transfer the learned extinction to suppress the context-induced renewal/relapse. Thus, because the ability to cease drug-seeking relies on overcoming drug-associated memories, extinction represents a preclinical opportunity to characterize and manipulate the molecular substrates underlying drug-seeking behavior to overcome the renewal-associated relapse. While drug self-administration (SA) leads to numerous neuroplasticity changes in the reward circuit, little is known about the impact of extinction training in reprogramming the addiction-relevant behavioral and transcriptomic codes/outcomes of the brain reward circuit. Together, these research questions pose a platform to delineate my current personal and professional training plan, which will be applied as I transition to a faculty position. Under the tutelage of my primary mentors (Drs. Eric Nestler: sponsor and Paul Kenny: co-sponsor) and my mentoring committee (Drs. Mary Kay Lobo, Yavin Shaham, Li Shen and Fabricio Do Monte), I will use RNA-sequencing of NAc subregions (core and shell) of rats receiving cocaine-SA and contextual extinction (AAA vs ABA) or withdrawal (no extinction) procedures, to characterize the drug-associated memories (phenotypes; renewal vs. extinction), at the transcriptional level (Aim 1). Subsequently, to manipulate the resulting behaviors, I will be targeting the transcriptome of NAc subregions and cell types. Specifically, I will design novel viral vectors to perform viral-mediated gene transfer to manipulate a top hub gene (i.e., transcription factor) previously proven or newly deduced as a main driver of renewal-induced relapse (failure of extinction transfer) in a subregion and cell-specific manner in NAc. As for the cell-specific manipulations, I will be utilizing the novel transgenic rat model expressing Cre-recombinase in dopamine D1 or D2 medium spiny neurons (MSNs) (Aim 2). Purposely, because life situations involving conflict between abstaining from or taking a drug due to adverse consequences are a key feature of relapse, I will test the impact of extinction training on restoring adaptive decisions in a conflict-based model (Aim 3), where drug seeking leads to punishable outcomes (i.e., footshocks), to delve deeper into the neurobiology of extinction/renewal that is most relevant to people.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
